Oak Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Oak Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$686K	Hold	1,100	–	–	0.22%	72
2026 Q1	$850K	Hold	1,100	–	–	0.29%	64
2025 Q4	$849K	Hold	1,100	–	–	0.29%	67
2025 Q3	$618K	Sell	1,100 -410	-27%	-$232K	0.21%	73
2025 Q2	$793K	Sell	1,510 -125	-8%	-$69.8K	0.28%	66
2025 Q1	$1.04M	Hold	1,635	–	–	0.38%	56
2024 Q4	$1.16M	Hold	1,635	–	–	0.43%	55
2024 Q3	$1.72M	Sell	1,635 -150	-8%	-$167K	0.61%	48
2024 Q2	$1.88M	Sell	1,785 -25	-1%	-$24.2K	0.69%	45
2024 Q1	$1.74M	Sell	1,810 -50	-3%	-$47.5K	0.65%	47
2023 Q4	$1.63M	Sell	1,860 -25	-1%	-$20.6K	0.65%	46
2023 Q3	$1.55M	Hold	1,885	–	–	0.67%	46
2023 Q2	$1.35M	Hold	1,885	–	–	0.56%	49
2023 Q1	$1.55M	Hold	1,885	–	–	0.67%	45
2022 Q4	$1.36M	Sell	1,885 -410	-18%	-$303K	0.61%	46
2022 Q3	$1.58M	Buy	+2,295	New	+$1.44M	0.77%	44
2022 Q2	–	Sell	-2,295	Closed	-$1.6M	–	142
2022 Q1	$1.6M	Hold	2,295	–	–	0.63%	46
2021 Q4	$1.45M	Hold	2,295	–	–	0.55%	49
2021 Q3	$1.25M	Hold	2,295	–	–	0.52%	52
2021 Q2	$1.28M	Buy	+2,295	New	+$1.16M	0.54%	50
2021 Q1	–	Sell	-2,295	Closed	-$1.11M	–	82
2020 Q4	$1.11M	Hold	2,295	–	–	0.54%	47
2020 Q3	$1.32M	Hold	2,295	–	–	0.7%	43
2020 Q2	$1.43M	Hold	2,295	–	–	0.85%	40
2020 Q1	$1.12M	Hold	2,295	–	–	0.81%	44
2019 Q4	$862K	Hold	2,295	–	–	0.48%	52
2019 Q3	$637K	Hold	2,295	–	–	0.38%	59
2019 Q2	$681K	Buy	+2,295	New	+$764K	0.42%	58
2018 Q1	–	Sell	-745	Closed	-$280K	–	90
2017 Q4	$280K	Buy	+745	New	+$302K	0.21%	76

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

HCM

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Oak Asset Management's REGN Position: Q2 2026 in Review

Oak Asset Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 1,100 shares worth $686K. The position accounts for 0.22% of the portfolio, ranked #72.

Oak Asset Management first reported a position in REGN in Q4 2017 and has held it in 28 quarters since. The position peaked at $1.88M in Q2 2024. 237 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Oak Asset Management held 1,100 shares of Regeneron Pharmaceuticals worth $686K as of Q2 2026.
Oak Asset Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.22% of Oak Asset Management's portfolio in Q2 2026, its #72 holding.
Oak Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2017 and has held it in 28 quarters since.
Oak Asset Management's Regeneron Pharmaceuticals position peaked at $1.88M in Q2 2024.
237 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Oak Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.